Vivo Bio Tech Limited (BOM:511509)

Vivo Bio Tech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 14, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	716	583	639	288	566	636
Market Cap Growth	-8.74%	-8.74%	122.12%	-49.14%	-11.02%	154.23%
Enterprise Value	1,243	1,148	1,225	915	844	885
Last Close Price	35.99	33.97	42.87	19.30	39.65	47.90
PE Ratio	7.56	8.01	25.29	10.86	25.69	11.19
PS Ratio	1.53	1.25	1.41	0.55	1.10	1.23
PB Ratio	0.92	0.75	1.17	0.56	1.20	1.50
P/TBV Ratio	1.32	1.08	1.38	0.70	1.69	2.04
P/FCF Ratio	-	-	8.44	2.65	-	-
P/OCF Ratio	6.05	4.93	4.12	1.94	3.40	4.48
EV/Sales Ratio	2.66	2.46	2.70	1.75	1.64	1.71
EV/EBITDA Ratio	6.06	5.60	6.45	4.72	5.90	5.28
EV/EBIT Ratio	10.82	9.99	10.38	7.48	10.08	7.33
EV/FCF Ratio	-11.91	-	16.18	8.44	-	-
Debt / Equity Ratio	0.69	0.69	1.34	1.20	1.43	0.73
Debt / EBITDA Ratio	2.63	2.63	3.85	3.22	4.72	1.85
Debt / FCF Ratio	-	-	9.65	5.76	-	-
Asset Turnover	0.33	0.33	0.35	0.43	0.51	0.72
Inventory Turnover	0.70	0.70	0.50	0.80	1.01	0.61
Quick Ratio	0.48	0.48	0.38	0.68	0.63	0.39
Current Ratio	1.51	1.51	1.25	1.27	1.12	1.24
Return on Equity (ROE)	11.01%	11.01%	4.75%	5.35%	4.91%	15.04%
Return on Assets (ROA)	5.12%	5.12%	5.67%	6.23%	5.18%	10.54%
Return on Capital (ROIC)	5.54%	5.54%	6.10%	6.68%	5.56%	11.53%
Return on Capital Employed (ROCE)	10.00%	10.00%	11.90%	12.50%	8.40%	20.90%
Earnings Yield	10.17%	12.49%	3.95%	9.21%	3.89%	8.94%
FCF Yield	-14.58%	-17.91%	11.85%	37.67%	-60.95%	-13.60%
Buyback Yield / Dilution	8.28%	8.28%	-12.53%	-4.66%	-4.44%	-5.23%

Updated Jan 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.